BranchLab's pages lead with four big numbers (+70% audience quality, +65% qualified reach, 2x script lift, 10x ROI), "independently verified by leading third-party measurement providers", and the homepage shows logos from GSK, Amgen, Biogen and the big agency networks. But none of the 49 pages on the site is a case study: there is no therapeutic area, no campaign, no named measurement partner and no method behind any number. The new Sales Director is told to win deals "using approved evidence" and to "use campaign results to expand into additional brands". Pharma brand and media teams, and their procurement and medical-legal reviewers, need to see a result in their own category before they take a meeting.
First action
List the campaigns behind the four headline numbers and which clients would allow a named or anonymised story.
How to measure it
Meetings booked from evidence pages
- Now
- –
- Target
- 15 a quarter
- By
- 2 quarters
Steps
Inventory results
Campaigns, therapeutic areas, measurement providers and outcomes.
Senior Data Scientist 1 week
Ask clients
Named, anonymised or not shareable for each result.
Client Success Manager 2 weeks
Write the template
Goal, audience approach, comparison, method, result.
VP of Growth Marketing 2 days
Draft three pages
The three therapeutic areas with the strongest results.
VP of Growth Marketing 1 week
Review
Legal, privacy and client approval for every claim.
Legal and Privacy 2 weeks
Publish and link
From audience performance, solutions and proposals.
Brand & Marketing Designer 3 days
Arm sellers
One-page PDF per result for proposals.
Sales Director / Account Executive 1 week
Add more
One new result a month.
VP of Growth Marketing monthly
Why it works
Build an approved evidence library, anonymised where a brand cannot be named: one page per therapeutic area (for example dermatology, metabolic disease, respiratory) with the campaign goal, the audience approach, the comparison (claims-based audience or incumbent vendor), the measurement provider type and method, and the result. Have each page reviewed by legal and the client, then link them from the audience-performance page, the solution pages and every proposal.
Specific results in the buyer's own therapeutic area turn headline claims into proof, give sellers approved material for proposals, and make the footnote on the performance numbers checkable.
Ready to use
ChecklistEvidence page template
[ ] Therapeutic area and audience type (patient, HCP, caregiver) [ ] Campaign objective [ ] What it was compared with [ ] Measurement provider type and method [ ] Result with the time window [ ] Brand named or anonymised, with client approval [ ] Legal and privacy review date [ ] Request Access link for that therapeutic area
Risks and how to handle them
Clients will not be named
Publish by therapeutic area and measurement method, without the brand.
Claims need review
Route every page through legal before it goes live.
Evidence
- Your websiteAudience Performance and "What is a Semantic Activation Platform?" pages: "Audience Quality +70%", "Qualified Reach +65%", "Script Lift +2x", "Return on Investment +10x", footnoted "*Mean performance independently verified by leading third-party measurement providers". The Series A release says BranchLab "has delivered an average increase of nearly 70% in marketing efficacy across a diverse set of therapeutic areas".Source
- Your websiteSitemap (49 URLs, October 22, 2026): home, about, Pathwai, three solution pages (pharma manufacturers, advertising agencies, publishers and platforms), demo, contact, careers, the privacy tracker, the Semantic Activation Platform explainer, audience performance, 31 insights posts and legal pages. No case studies, results by therapeutic area, named measurement partners, integration or activation-partner pages, or product documentation.Source
- Your websiteHomepage logo strips "Trusted by the World's Leading Healthcare Commercialization Teams" and "Empowering Leading Healthcare Agencies" show logos including GSK, Eisai, Biogen, Amgen, Astellas, Boehringer, Otsuka and Sarepta, and WPP Media, IPG Mediabrands, Havas, OMD, EVERSANA, dentsu, Real Chemistry and Publicis Health Media. The logo images carry empty alt text, so screen readers and search engines see no names.Source
- HiringSales Director / Account Executive (NYC, posted October 21, 2026), reporting to the CRO: a "quota-carrying" seller to "win new business, grow strategic accounts, and turn customer priorities into funded campaigns"; will "Connect BranchLab's audiences and Pathwai's planning, activation, and measurement capabilities to campaign objectives, using approved evidence to develop persuasive proposals" and "use campaign results to expand into additional brands, audiences, and enterprise partnerships". An Enterprise Sales role (posted September 22, 2026) will "Represent BranchLab at industry events, conferences" and "Drive account expansion opportunities by identifying additional use cases, products, channels".Source
- Your websiteBranchLab raised a $26 million Series A led by McKesson Ventures with FCA Venture Partners, Sanofi Ventures and AIX Ventures (May 13, 2026), bringing total funding to $35 million; the platform uses "a novel transformer-based architecture that enables models to train on health data within customer-controlled environments".Source